Bioventus, Inc. (BVS)
8.74
-0.03
(-0.34%)
USD |
NASDAQ |
Mar 03, 16:00
8.735
0.00 (0.00%)
Pre-Market: 20:00
Bioventus Price : 8.74 for March 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Abbott Laboratories | 113.61 |
| Accuray, Inc. | 0.5263 |
| Alphatec Holdings, Inc. | 13.02 |
| Boston Scientific Corp. | 73.85 |
| Plus Therapeutics, Inc. | 0.2932 |
Price Related Metrics
| PE Ratio | 77.90 |
| PS Ratio | 1.042 |
| Price to Book Value | 3.524 |
| Price to Free Cash Flow | 10.99 |
| Earnings Yield | 1.28% |
| Market Cap | 585.37M |
| Operating PE Ratio | 12.24 |
| Normalized PE Ratio | 55.53 |